Covered recipient · General Payments record
KEVIN ZACHAROFF
Allopathic & Osteopathic Physicians Anesthesiology
General Payments · PY2018–2024
$7,663.85
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,134.20 | 4 |
| Travel and Lodging | $387.50 | 7 |
| Food and Beverage | $70.14 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Aurobindo Pharma USA, Inc. | $4,262.14 | 5 |
| Tris Pharma Inc | $2,250.00 | 2 |
| Mylan Inc. | $1,079.70 | 12 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aurobindo Pharma USA, Inc. | $137.81 | 09/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154760869 | CMS |
| Aurobindo Pharma USA, Inc. | $29.47 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154760933 | CMS |
| Aurobindo Pharma USA, Inc. | $4,033.32 | 10/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153786924 | CMS |
| Aurobindo Pharma USA, Inc. | $5.60 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154349548 | CMS |
| Aurobindo Pharma USA, Inc. | $55.94 | 10/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154349569 | CMS |
| Mylan Inc. | $8.14 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147272368 | CMS |
| Mylan Inc. | $55.35 | 09/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147272378 | CMS |
| Mylan Inc. | $4.73 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147272426 | CMS |
| Mylan Inc. | $1.60 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147272440 | CMS |
| Mylan Inc. | $11.93 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147272442 | CMS |
| Mylan Inc. | $27.28 | 09/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147272454 | CMS |
| Mylan Inc. | $3.07 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147272512 | CMS |
| Mylan Inc. | $55.18 | 09/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147272522 | CMS |
| Mylan Inc. | $50.94 | 10/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147272274 | CMS |
| Mylan Inc. | $5.60 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147272306 | CMS |
| Mylan Inc. | $5.00 | 10/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147272310 | CMS |
| Mylan Inc. | $850.88 | 10/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1147272324 | CMS |
| Tris Pharma Inc | $500.00 | 09/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1147203195 | CMS |
| Tris Pharma Inc | $1,750.00 | 11/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1147203197 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.